• 我要登录|
  • 免费注册
    |
  • 我的丁香通
    • 企业机构:
    • 成为企业机构
    • 个人用户:
    • 个人中心
  • 移动端
    移动端
丁香通 logo丁香实验_LOGO
搜实验

    大家都在搜

      大家都在搜

        0 人通过求购买到了急需的产品
        免费发布求购
        发布求购
        点赞
        收藏
        wx-share
        分享

        Blood-Brain Barrier Genomics

        互联网

        603
        The application of the suppressive subtraction hybridization (SSH) technique to blood-brain barrier (BBB) genomics has accelerated the discovery and identification of BBB-specific genes in humans and in experimental animals ( 13 ). This procedure allows for the development of gene arrays based on gene products derived from isolated brain capillaries, which represents the BBB in vivo ( 4 ). The brain capillary volume is 10 −3 or less than 0.1% of the total brain ( 4 ). Because the sensitivity of a typical gene microarray of the brain approximates 10 −4 ( 5 ), the identification of BBB-specific genes from gene arrays derived from whole brain is statistically unlikely, even for BBB highly expressed transcript with relative abundance ranging 0.01–0.02% (i.e., actin, LAT1) ( 6 , 7 ). In addition, the levels of low abundant BBB-specific genes, like the p80 BBB-GLUT1 mRNA-binding protein, are less than 0.0005% of total cell proteins ( 8 ), which is several log orders below the limit of detection of deoxyribonucleic acid (DNA) microarrays ( 5 ). However, BBB-specific genes can be identified with a gene array derived from gene products initially obtained from isolated brain capillaries (Fig. 1 ).
        Fig. 1.  Diagram of the blood-brain barrier genomics program. BSP, blood-brain barrier specific protein.

        ad image
        提问
        扫一扫
        丁香实验小程序二维码
        实验小助手
        丁香实验公众号二维码
        扫码领资料
        反馈
        TOP
        打开小程序